BioTelemetry (NASDAQ: BEAT) reported Q3 EPS of $0.21, $0.03 better than the analyst estimate of $0.18. Revenue for the quarter came in at $53.1 million versus the consensus estimate of $52.92 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.